Cargando…

Targeted Approaches to T-Cell Lymphoma

The T-cell lymphomas are a rare group of Non-Hodgkin’s lymphomas derived from mature T-lymphocytes. They are divided broadly into the Peripheral T-cell lymphomas and the Cutaneous T-cell lymphomas. Clinical outcomes vary widely but are generally unsatisfactory with current treatments. The developmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrop, Sean, Abeyakoon, Chathuri, Van Der Weyden, Carrie, Prince, H. Miles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229513/ https://www.ncbi.nlm.nih.gov/pubmed/34072040 http://dx.doi.org/10.3390/jpm11060481

Ejemplares similares

Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma
por: Abeyakoon, Chathuri, et al.
Publicado: (2020)

An Update on the Current Genomic Landscape of Breast Implant-Associated Anaplastic Large Cell Lymphoma
por: Harrop, Sean, et al.
Publicado: (2021)

Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions
por: van der Weyden, C A, et al.
Publicado: (2017)

Contemporary approaches for modifying the mouse genome
por: Adams, David J., et al.
Publicado: (2008)

Lack of Durable Remission with Conventional-Dose Total Skin Electron Therapy for the Management of Sezary Syndrome and Multiply Relapsed Mycosis Fungoides
por: Campbell, Belinda A., et al.
Publicado: (2019)

International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies
por: Campbell, Belinda A., et al.
Publicado: (2023)

Definitions of massive transfusion in adults with critical bleeding: a systematic review
por: Lin, Victor S., et al.
Publicado: (2023)

The Ras-association domain family (RASSF) members and their role in human tumourigenesis
por: van der Weyden, Louise, et al.
Publicado: (2007)

Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma
por: Yu, Tiantian, et al.
Publicado: (2023)

Targeting TET2 as a Therapeutic Approach for Angioimmunoblastic T Cell Lymphoma
por: Hu, Lina, et al.
Publicado: (2022)

Metastasis in the wild: investigating metastasis in non-laboratory animals
por: Abu-Helil, Bushra, et al.
Publicado: (2019)

Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research
por: Deva, Anand K., et al.
Publicado: (2020)

Update and new approaches in the treatment of Castleman disease
por: Chan, Kah-Lok, et al.
Publicado: (2016)

Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives
por: Prince, H. Miles, et al.
Publicado: (2022)

Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance
por: Barraclough, Allison, et al.
Publicado: (2023)

Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen
por: Harrop, Richard, et al.
Publicado: (2019)

Spotlight on Feline Oncology
por: van der Weyden, Louise
Publicado: (2023)

Cancer gene discovery in mouse and man
por: Mattison, Jenny, et al.
Publicado: (2009)

Feline Oncogenomics: What Do We Know about the Genetics of Cancer in Domestic Cats?
por: Ludwig, Latasha, et al.
Publicado: (2022)

S304: WHAT IS A MASSIVE TRANSFUSION? A SCOPING REVIEW TO INFORM AN INTERNATIONAL CONSENSUS DEFINITION
por: Lin, Victor, et al.
Publicado: (2023)

Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma
por: Foss, Francine, et al.
Publicado: (2014)

Peripheral T-Cell Lymphomas: Therapeutic Approaches
por: Sibon, David
Publicado: (2022)

Flow cytometry for the assessment of blood tumour burden in cutaneous T‐cell lymphoma: towards a standardized approach
por: Vermeer, Maarten H., et al.
Publicado: (2022)

Novel targeted therapies of T cell lymphomas
por: Iżykowska, Katarzyna, et al.
Publicado: (2020)

Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T‐cell lymphoma
por: Foss, Francine, et al.
Publicado: (2016)

Adoptive T-cell therapy for Hodgkin lymphoma
por: Ho, Carrie, et al.
Publicado: (2021)

Targeted Therapy in Follicular Lymphoma: Towards a Chemotherapy-Free Approach
por: Chen, Chung-Jiah J., et al.
Publicado: (2023)

The ICMJE and URM: Providing Independent Advice for the Conduct of Biomedical Research and Publication
por: Van der Weyden, Martin B
Publicado: (2007)

On being the Editor of the Medical Journal of Australia: Living dangerously
por: Van Der Weyden, Martin B.
Publicado: (2012)

The mouse genetics toolkit: revealing function and mechanism
por: van der Weyden, Louise, et al.
Publicado: (2011)

Angiogenesis in cutaneous T-cell lymphoma - proteomic approaches
por: Tanase, Cristiana, et al.
Publicado: (2019)

Targeted therapy in lymphoma
por: Johnston, Patrick B, et al.
Publicado: (2010)

Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas
por: Poggio, Teresa, et al.
Publicado: (2018)

Treatment approaches in relapsed or refractory peripheral T-cell lymphomas
por: Foster, Cheryl, et al.
Publicado: (2020)

Advances and Personalized Approaches in the Frontline Treatment of T-Cell Lymphomas
por: Angelos, Mathew G., et al.
Publicado: (2022)

Controversies in Targeted Therapy of Adult T Cell Leukemia/Lymphoma: ON Target or OFF Target Effects?
por: Nasr, Rihab, et al.
Publicado: (2011)

Updating targets for natural killer/T-cell lymphoma immunotherapy
por: Xue, Weili, et al.
Publicado: (2021)

Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells
por: Frazzi, Raffaele, et al.
Publicado: (2017)

Epigenetic targets in B- and T-cell lymphomas: latest developments
por: Ribeiro, Marcelo Lima, et al.
Publicado: (2023)

Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma
por: Major, Ajay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2mb69ngcus78e3nlm573ller9i